Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-057372)

Filing Details

Accession Number:: 0001209191-18-057372
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2018-11-06 16:12:15
Reporting Period:: 2018-09-12

Accepted Time:: 2018-11-06 16:12:15
Original Submission Date:: 2018-09-13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1439222	Agios Pharmaceuticals Inc	AGIO	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1180432	John Maraganore	C/O Agios Pharmaceuticals, Inc. 88 Sidney Street Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-09-12	0	$0.00	36,209	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

On September 13, 2018, the reporting person filed a Form 4 reporting the sale of 14,162 shares of common stock. The previously reported transaction was subsequently broken and unwound by the broker and, therefore, did not in fact occur for the reporting person's account. As of September 12, 2018, the reporting person beneficially owned 36,209 shares of common stock of Agios Pharmaceuticals, Inc.